Valneva SE

Valneva SEverified

VALN

Price:

$5.355

Market Cap:

$433.53M

Valneva SE operates as a specialized biopharmaceutical company, concentrating its efforts on developing and bringing to market preventative vaccines for infectious diseases where current medical options are insufficient. Its portfolio of commercial travel vaccines includes IXIARO, an inactivated vaccine derived from Vero cell culture, which provides active immunity against Japanese encephalitis. Another offering is DUKORAL, an oral vaccine designed to guard against diarrhea induced by Vibrio cholerae or enterotoxigenic Escherichia coli (ETEC) bacteria. The company's development pipeline features VLA2001, a candidate vaccine targeting SARS-CoV-2. Additionally, Valneva is progressing with VLA1...[Read more]

Industry

Biotechnology

IPO Date

2021-05-05

Stock Exchange

NASDAQ

Ticker

VALN

The Enterprise Value as of June 2026 (TTM) for Valneva SE (VALN) is 537.77M

According to Valneva SE’s latest financial reports and current stock price. The company's current Enterprise Value is 537.77M. This represents a change of -17.45% compared to the average of 651.43M of the last 4 quarters.

Valneva SE (VALN) Historical Enterprise Value (quarterly & annually)

How has VALN Enterprise Value performed in the past?

The mean historical Enterprise Value of Valneva SE over the last ten years is 619.75M. The current 537.77M Enterprise Value has changed 8.58% with respect to the historical average. Over the past ten years (40 quarters), VALN's Enterprise Value was at its highest in in the December 2021 quarter at 2.24B. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.

Quarterly (TTM)
Annual

Average

619.75M

Median

472.21M

Minimum

235.79M

Maximum

2.16B

Valneva SE (VALN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Valneva SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 257.31%

Maximum Annual Enterprise Value = 2.16B

Minimum Annual Increase = -73.07%

Minimum Annual Enterprise Value = 235.79M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025723.22M99.36%
2024362.77M-50.88%
2023738.55M26.97%
2022581.66M-73.07%
20212.16B257.31%
2020604.43M135.59%
2019256.56M8.81%
2018235.79M-8.21%
2017256.87M-7.58%
2016277.93M-18.87%

Valneva SE (VALN) Average Enterprise Value

How has VALN Enterprise Value performed in the past?

The current Enterprise Value of Valneva SE (VALN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

608.18M

5-year avg

913.18M

10-year avg

619.75M

Valneva SE (VALN) Enterprise Value vs. Peers

How is VALN’s Enterprise Value compared to its peers?

Valneva SE’s Enterprise Value is less than Day One Biopharmaceuticals, Inc. (2.03B), greater than Arvinas, Inc. (410.37M), less than ArriVent BioPharma, Inc. Common Stock (1.36B), less than Astria Therapeutics, Inc. (626.31M), less than Geron Corporation (918.81M), less than Replimune Group, Inc. (686.64M), less than MeiraGTx Holdings plc (904.12M), less than MBX Biosciences, Inc. Common Stock (1.15B), less than Ginkgo Bioworks Holdings, Inc. (782.25M), less than Iovance Biotherapeutics, Inc. (1.31B),

Build a custom stock screener for Valneva SE (VALN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valneva SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Valneva SE (VALN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Valneva SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Valneva SE's Enterprise Value?

What is the highest Enterprise Value for Valneva SE (VALN)?

What is the 3-year average Enterprise Value for Valneva SE (VALN)?

What is the 5-year average Enterprise Value for Valneva SE (VALN)?

How does the current Enterprise Value for Valneva SE (VALN) compare to its historical average?